Addressing Disparities in the Quality of Breast Cancer Chemotherapy

Jennifer J. Griggs, Melony E. Sorbero

ResearchPosted on rand.org 2005Published in: Clinical Breast Cancer, v. 6, no. 3, Commentary, Aug. 2005, p. 267-269

Commentary on a study in this issue that examines disparities in the quality of breast cancer adjuvant chemotherapy received by black and white women within a university setting, and found that black women are more likely than white women to have delays in administration of chemotherapy, reductions in doses, and premature discontinuation of therapy.

Read More

Topics

Document Details

  • Copyright: Aging and Public Policy: demographic and Economic Perspectives, a supplement to Population and Development Review
  • Publisher: Aging and Public Policy: demographic and Economic Perspectives, a supplement to Population and Development Review
  • Availability: Non-RAND
  • Year: 2005
  • Pages: 3
  • DOI: https://doi.org/10.7249/pubs
  • Document Number: EP-200508-27

This publication is part of the RAND external publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.

RAND is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.